accountpreventing drug development partner Eli Lilly and Co. from using the same sales force to sell an Amylin-developed type 2 diabetes treatment, Byetta, and Boehringer Ingelheim's Tradjenta.REACTION: Lilly said it was disappointed in the decision but will...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Summary Box: Lilly receives restraining order
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account